home / stock / nvno / nvno quote
Last: | $5.20 |
---|---|
Change Percent: | -1.5% |
Open: | $5.42 |
Close: | $5.20 |
High: | $5.46 |
Low: | $4.99 |
Volume: | 67,948 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.2 | $5.42 | $5.2 | $5.46 | $4.99 | 67,948 | 06-25-2024 |
$5.34 | $4.99 | $5.34 | $5.69 | $4.79 | 196,179 | 06-24-2024 |
$5 | $4.61 | $5 | $5 | $4.29 | 2,511,192 | 06-21-2024 |
$4.67 | $4.66 | $4.67 | $4.81 | $4.65 | 65,043 | 06-20-2024 |
$4.7 | $4.8 | $4.7 | $4.89 | $4.7 | 30,222 | 06-19-2024 |
$4.7 | $4.8 | $4.7 | $4.89 | $4.7 | 30,222 | 06-18-2024 |
$4.89 | $4.725 | $4.89 | $4.9 | $4.7 | 24,800 | 06-17-2024 |
$4.77 | $4.7 | $4.77 | $4.7986 | $4.6117 | 26,664 | 06-14-2024 |
$4.72 | $4.74 | $4.72 | $4.805 | $4.7112 | 16,228 | 06-13-2024 |
$4.79 | $4.78 | $4.79 | $4.85 | $4.7001 | 27,953 | 06-12-2024 |
$4.76 | $4.69 | $4.76 | $4.76 | $4.6516 | 12,626 | 06-11-2024 |
$4.7 | $4.68 | $4.7 | $4.775 | $4.66 | 16,737 | 06-10-2024 |
$4.68 | $4.88 | $4.68 | $4.88 | $4.68 | 23,201 | 06-07-2024 |
$4.89 | $4.7 | $4.89 | $4.89 | $4.63 | 60,062 | 06-06-2024 |
$4.75 | $4.8599 | $4.75 | $4.87 | $4.64 | 26,147 | 06-05-2024 |
$4.73 | $4.79 | $4.73 | $4.79 | $4.6201 | 27,247 | 06-04-2024 |
$4.76 | $4.86 | $4.76 | $4.914 | $4.68 | 66,259 | 06-03-2024 |
$4.77 | $4.885 | $4.77 | $5.01 | $4.77 | 59,043 | 05-31-2024 |
$4.82 | $4.9461 | $4.82 | $4.9522 | $4.81 | 43,422 | 05-30-2024 |
$4.94 | $4.8958 | $4.94 | $5.1 | $4.82 | 40,109 | 05-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
enVVeno Medical Corp Com Company Name:
NVNO Stock Symbol:
NASDAQ Market:
Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, June 27 th at 4:00 PM ET IRVINE, CA / ACCESSWIRE / June 25, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatmen...
91% of Venous Ulcer Patients Evaluated at One Year Have Either Fully Healed Ulcers or Ulcers That Have Improved 100% of Venous Ulcers with a Duration of One Year or Less Prior to VenoValve Surgery Have Fully Healed 89% of Venous Ulcers with a Duration of More Than One Year Prior to Veno...
IRVINE, CA / ACCESSWIRE / June 17, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be ...